These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2696022)

  • 21. Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer?
    Valero V; Hortobagyi GN
    J Clin Oncol; 2003 Mar; 21(6):959-62. PubMed ID: 12637456
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy and hormone therapy of metastatic breast cancer.
    Paterson AH
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):631-3. PubMed ID: 3835708
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
    Goldhirsch A; Gelber RD
    Recent Results Cancer Res; 1989; 115():153-62. PubMed ID: 2696027
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical trials referral resource. Adjuvant therapy of breast cancer.
    Cheson BD
    Oncology (Williston Park); 1989 Jun; 3(6):70-1, 74-5, 78. PubMed ID: 2534915
    [No Abstract]   [Full Text] [Related]  

  • 25. What did we learn from the results of the international overview about the effects of endocrine therapy?
    Bonadonna G
    Recent Results Cancer Res; 1993; 127():159-61. PubMed ID: 8502811
    [No Abstract]   [Full Text] [Related]  

  • 26. [Taxanes in primary systemic treatment of breast cancer].
    von Minckwitz G
    Onkologie; 2003 Dec; 26 Suppl 7():21-5. PubMed ID: 14716138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant therapy for node-negative breast cancer: a proactive view.
    Glick JH
    Important Adv Oncol; 1990; ():183-97. PubMed ID: 2182518
    [No Abstract]   [Full Text] [Related]  

  • 28. The Cancer Research Campaign trials of adjuvant therapy for early breast cancer.
    Baum M; Ebbs SR; Houghton J; A'Hern RP; Riley D
    Acta Oncol; 1989; 28(6):907-12. PubMed ID: 2692654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy in breast cancer.
    Robert NJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer.
    Kaufmann M; Jonat W; Abel U; Hilfrich J; Caffier H; Kreienberg R; Trams G; Brunnert K; Schermann J; Kleine W
    J Clin Oncol; 1993 Mar; 11(3):454-60. PubMed ID: 8445420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer.
    Bianco AR; De Placido S; Perrone F; Carlomagno C; De Laurentiis M; Del Mastro L; Lauria R; Marinelli A; Gallo C
    Ann N Y Acad Sci; 1993 Nov; 698():330-8. PubMed ID: 8279772
    [No Abstract]   [Full Text] [Related]  

  • 32. [The ATAC study on adjuvants in breast cancer].
    Bravi S
    Suppl Tumori; 2004; 3(4):S15. PubMed ID: 15206200
    [No Abstract]   [Full Text] [Related]  

  • 33. HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer.
    Berry DA; Muss HB; Thor AD; Dressler L; Liu ET; Broadwater G; Budman DR; Henderson IC; Barcos M; Hayes D; Norton L
    J Clin Oncol; 2000 Oct; 18(20):3471-9. PubMed ID: 11032587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal manipulation in the adjuvant treatment of breast cancer.
    Honig SF; Swain SM
    Important Adv Oncol; 1993; ():103-23. PubMed ID: 8505047
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant therapy for node-negative breast cancer: a cautious interpretation.
    Henderson IC
    Important Adv Oncol; 1990; ():199-216. PubMed ID: 1691137
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of adjuvant chemotherapy in male breast cancer.
    Patel HZ; Buzdar AU; Hortobagyi GN
    Cancer; 1989 Oct; 64(8):1583-5. PubMed ID: 2676137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].
    Gamucci T
    Suppl Tumori; 2004; 3(4):S16. PubMed ID: 15206201
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjuvant chemotherapy for node-negative breast cancer patients.
    Bonadonna G; Zambetti M; Valagussa P
    Recent Results Cancer Res; 1989; 115():175-9. PubMed ID: 2516350
    [No Abstract]   [Full Text] [Related]  

  • 39. Critical review of adjuvant therapy in premenopausal patients.
    Mouridsen HT
    Recent Results Cancer Res; 1989; 115():132-5. PubMed ID: 2623330
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adjuvant treatment of breast carcinoma].
    Bruning PF; Bartelink H; van Dongen JA; Peterse JL
    Ned Tijdschr Geneeskd; 1993 Nov; 137(46):2364-70. PubMed ID: 8264820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.